Used in research settings as a selective inhibitor targeting specific kinase pathways involved in cellular proliferation. Shows potential in early-stage studies for oncology applications, particularly in models of resistant tumor types. Demonstrates high permeability and stability in cellular assays, making it suitable for in vitro and in vivo proof-of-concept experiments. Currently not approved for clinical use, but serves as a tool compound for validating therapeutic targets in cancer signaling networks.